Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer.

Skoulidis F, Li BT, Hochmair M, Govindan R, Vincent M, van der Wekken AJ, Reguart Aransay N, O'Byrne KJ, Girard N, Griesinger F, Nishio M, Häfliger S, Lindsay C, Reinmuth N, Paulus A, Papakotoulas P, Kim SW, Ferreira CG, Pasello G, Duruisseaux M, Gennatas S, Dimou A, Mehta B, Kormany W, Nduka C, Sylvester BE, Ardito-Abraham C, Wang Y, de Langen AJ

Open source

DOI: 10.1093/oncolo/oyae356
Published: 2025 Jan 17
Container: The oncologist
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyae356,
  title = {Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer.},
  author = {Skoulidis F and Li BT and Hochmair M and Govindan R and Vincent M and van der Wekken AJ and Reguart Aransay N and O'Byrne KJ and Girard N and Griesinger F and Nishio M and Häfliger S and Lindsay C and Reinmuth N and Paulus A and Papakotoulas P and Kim SW and Ferreira CG and Pasello G and Duruisseaux M and Gennatas S and Dimou A and Mehta B and Kormany W and Nduka C and Sylvester BE and Ardito-Abraham C and Wang Y and de Langen AJ},
  year = {2025},
  journal = {The oncologist},
  doi = {10.1093/oncolo/oyae356},
  url = {https://doi.org/10.1093/oncolo/oyae356}
}

RIS

TY  - JOUR
TI  - Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer.
AU  - Skoulidis F
AU  - Li BT
AU  - Hochmair M
AU  - Govindan R
AU  - Vincent M
AU  - van der Wekken AJ
AU  - Reguart Aransay N
AU  - O'Byrne KJ
AU  - Girard N
AU  - Griesinger F
AU  - Nishio M
AU  - Häfliger S
AU  - Lindsay C
AU  - Reinmuth N
AU  - Paulus A
AU  - Papakotoulas P
AU  - Kim SW
AU  - Ferreira CG
AU  - Pasello G
AU  - Duruisseaux M
AU  - Gennatas S
AU  - Dimou A
AU  - Mehta B
AU  - Kormany W
AU  - Nduka C
AU  - Sylvester BE
AU  - Ardito-Abraham C
AU  - Wang Y
AU  - de Langen AJ
PY  - 2025
JO  - The oncologist
DO  - 10.1093/oncolo/oyae356
UR  - https://doi.org/10.1093/oncolo/oyae356
ER  -

APA

F, S., BT, L., M, H., R, G., M, V., AJ, V. D. W., N, R. A., KJ, O., N, G., F, G., M, N., S, H., C, L., N, R., A, P., P, P., SW, K., CG, F., G, P., M, D., S, G., A, D., B, M., W, K., C, N., BE, S., C, A., Y, W., & AJ, D. L. (2025). Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer.. The oncologist. https://doi.org/10.1093/oncolo/oyae356

Source records

pubmed · retrieved 2026-09-26T00:25:36.105Z